Tiziana Life Sciences (TLSA) News Today $1.00 +0.02 (+2.04%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Tiziana Life Sciences secures grant for ALS trialNovember 19 at 8:47 AM | proactiveinvestors.comTiziana Life Sciences Ltd (NASDAQ:TLSA) Short Interest Up 350.5% in OctoberTiziana Life Sciences Ltd (NASDAQ:TLSA - Get Free Report) was the recipient of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 241,900 shares, an increase of 350.5% from the October 15th total of 53,700 shares. Based on an average trading volume of 268,900 shares, the days-to-cover ratio is currently 0.9 days. Approximately 0.4% of the shares of the stock are short sold.November 12, 2024 | marketbeat.comTiziana Life Sciences CEO discusses foralumab potential to enhance Ozempic - ICYMINovember 2, 2024 | proactiveinvestors.comTiziana Life Sciences to showcase breakthrough therapies at BIO-Europe 2024 ConferenceNovember 1, 2024 | proactiveinvestors.comTiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study DataNovember 1, 2024 | globenewswire.comTiziana Life Sciences secures funding to advance development of MS and Alzheimer's therapyOctober 31, 2024 | proactiveinvestors.comTiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 MillionOctober 30, 2024 | globenewswire.comTiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination StudyOctober 30, 2024 | tmcnet.comTiziana Life Sciences announces results from ozempic, nasal anti-CD3 studyOctober 30, 2024 | markets.businessinsider.comTiziana Life Sciences reports promising preclinical results for novel combination therapy targeting obesityOctober 30, 2024 | proactiveinvestors.comTiziana Life Sciences Advances with Promising Drug TrialsOctober 21, 2024 | finance.yahoo.comTiziana Life Sciences Ltd Share Chat (TLSA.US)October 18, 2024 | lse.co.ukTiziana Life Sciences Ltd (NASDAQ:TLSA) Short Interest UpdateTiziana Life Sciences Ltd (NASDAQ:TLSA - Get Free Report) saw a large increase in short interest in the month of September. As of September 30th, there was short interest totalling 60,600 shares, an increase of 44.6% from the September 15th total of 41,900 shares. Based on an average trading volume of 252,300 shares, the days-to-cover ratio is presently 0.2 days.October 14, 2024 | marketbeat.comTiziana Life Sciences awarded $4M to advance Alzheimer's disease researchSeptember 19, 2024 | proactiveinvestors.comTiziana Life Sciences Ltd (NASDAQ:TLSA) Short Interest Down 53.7% in AugustTiziana Life Sciences Ltd (NASDAQ:TLSA - Get Free Report) was the target of a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 127,100 shares, a decrease of 53.7% from the August 15th total of 274,700 shares. Based on an average trading volume of 265,800 shares, the short-interest ratio is currently 0.5 days.September 13, 2024 | marketbeat.comTiziana Life Sciences names new chief executiveAugust 19, 2024 | proactiveinvestors.comTiziana Life Sciences Appoints New Chief Executive OfficerAugust 19, 2024 | globenewswire.comTiziana Life Sciences Ltd.: Tiziana Life Sciences Granted FDA Fast Track DesignationJuly 25, 2024 | finanznachrichten.deTiziana Life Sciences secures FDA Fast Track status for MS therapy intranasal foralumabJuly 24, 2024 | proactiveinvestors.comTiziana Life Sciences Granted FDA Fast Track DesignationJuly 24, 2024 | globenewswire.comTiziana Life Sciences secures $3.4M in non-dilutive fundingJune 28, 2024 | proactiveinvestors.comTiziana Receives $3.4 Million in Non-Dilutive FundingJune 28, 2024 | globenewswire.comTiziana Life Sciences secures FDA approval to dose first patient with moderate Alzheimer's with investigational therapyJune 26, 2024 | proactiveinvestors.comTiziana Life Sciences to Dose First Patient with Moderate Alzheimer's Disease with ForalumabJune 26, 2024 | globenewswire.comTiziana Life Sciences seeks FDA Fast Track Designation for foralumab in MS treatmentJune 11, 2024 | proactiveinvestors.comTiziana Life Sciences reports qualitative improvement in MS patients treated with lead assetJune 6, 2024 | proactiveinvestors.comTiziana Life Sciences seeks funding from ALS Association for intranasal foralumab trialJune 4, 2024 | proactiveinvestors.comTiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis ResearchMay 30, 2024 | globenewswire.comTiziana eyes orphan drug designation for multiple sclerosis treatmentMay 13, 2024 | proactiveinvestors.comTiziana Life Sciences Files for Orphan Drug Designation for Intranasal ForalumabMay 13, 2024 | globenewswire.comTiziana Life Sciences Ltd Ordinary Shares TLSAMay 3, 2024 | morningstar.comTiziana Life Sciences unveils positive neuroimaging data for foralumab in MS patientsApril 25, 2024 | proactiveinvestors.comTiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal ForalumabApril 25, 2024 | globenewswire.comTiziana Life Sciences wins FDA approval to add patients to Multiple Sclerosis Expanded Access ProgramApril 23, 2024 | proactiveinvestors.comTiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access ProgramApril 23, 2024 | globenewswire.comTiziana Life Sciences reports additional positive results from Multiple Sclerosis programApril 22, 2024 | proactiveinvestors.comTiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients in its Expanded Access ProgramApril 22, 2024 | globenewswire.comTiziana Life Sciences' foralumab study highlighted in Neurology TodayApril 19, 2024 | proactiveinvestors.comTiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®April 19, 2024 | globenewswire.comTiziana Life Sciences says foralumab shows promise in stabilizing certain types of MSApril 18, 2024 | proactiveinvestors.comTiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of NeurologyApril 18, 2024 | globenewswire.comTiziana Life Sciences to present new imaging data for lead asset at upcoming neurology conferenceApril 11, 2024 | proactiveinvestors.comTiziana Life Sciences Announces Platform Presentation of New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of NeurologyApril 11, 2024 | globenewswire.comTLSA Tiziana Life Sciences LtdMarch 20, 2024 | seekingalpha.comTiziana Life Sciences Announces Podium Presentation at AD/PD of Nasal Anti-CD3 in Alzheimer’s DiseaseMarch 5, 2024 | finance.yahoo.comTiziana Life Sciences to present positive data for lead drug candidate in Alzheimer's diseaseMarch 5, 2024 | proactiveinvestors.comTiziana Life Sciences Announces Podium Presentation at AD/PD of Nasal Anti-CD3 in Alzheimer's DiseaseMarch 5, 2024 | globenewswire.comTiziana Life Sciences to Present at Biotech Showcase Conference in San Francisco, January 8-10, 2024January 5, 2024 | finance.yahoo.comTiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist for Additional Reduction of Obesity - Associated InflammationJanuary 5, 2024 | finance.yahoo.comTiziana Life Sciences starts Phase 2a trial and promises results in 2024December 22, 2023 | proactiveinvestors.com Get Tiziana Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TLSA and its competitors with MarketBeat's FREE daily newsletter. Email Address 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] TLSA Media Mentions By Week TLSA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TLSA News Sentiment▼1.000.45▲Average Medical News Sentiment TLSA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TLSA Articles This Week▼11▲TLSA Articles Average Week Get Tiziana Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TLSA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TKNO News Today TSHA News Today CGC News Today AKBA News Today FDMT News Today ALVO News Today LRMR News Today KALV News Today VERV News Today VALN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TLSA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tiziana Life Sciences Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Tiziana Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
